Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Lower urinary tract dysfunction in patients with multiple sclerosis.
Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
The effect of plasma exchange on serum anti-JC virus antibodies.
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE.
Iron accumulation in multiple sclerosis: an early pathogenic event.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
The Diagnosis and Treatment of Optic Neuritis.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Pages
« first
‹ previous
…
437
438
439
440
441
442
443
444
445
…
next ›
last »